[1] | Abramyan A.A., Rakhimbaeva G.S., Nasirdinova N.A. Clinical and biochemical markers of frontotemporal dementia and their relationship with the development of cognitive impairment. // Bulletin of the Tashkent Medical Academy - 2022 No. 9. - Pp. 107-112. |
[2] | Abramyan A.A., Rakhimbaeva G.S., Nasirdinova N.A. Features of cognitive impairment and neuroimaging in frontotemporal dementia. Peer-reviewed scientific and practical journal “Neurology” 3 (91), 2022, pp. 2-4. |
[3] | Abramyan A.A., Rakhimbaeva G.S., Nasirdinova N.A., Urinova G.G. Frontotemporal dementia. Scientific and abstract medical journal "New Day in Medicine" 3 (31) 2020: 570-573. |
[4] | Vasenina E.E., Levin O.S. Primary progressive aphasias // Journal of Neurology and Psychiatry. - 2014. -V. 6, No. 2. - P. 3-12. |
[5] | Levada O. A. Frontotemporal dementia: neurobiology, modern approaches to diagnostics and patient management // Journal « NeuroNews : psychoneurology and neuropsychiatry»: - 2013; 2-1. |
[6] | Levin O.S. Cognitive impairments in neurological practice. - M.: MEDpress-inform, 2013. - 272 p. |
[7] | Rozhivanov P.V., Vaks V.V. Dehydroepiandrosterone: physiological role and possibilities of use as a medicinal product. Problems Endocrinology. 2005; 51(2): 46-51. |
[8] | Stepkina D.A., Zakharov V.V., Yakhno N.N. Frontotemporal degeneration (review of literature and own observations). Doctor.Ru. 2013; (5): 44-50. |
[9] | Stepkina D.A., Zakharov V.V., Yakhno N.N. Non-cognitive neuropsychiatric disorders in primary progressive aphasia syndrome. Neurological journal. 2014; 19 (6): 17-22. |
[10] | Stepkina D.A., Zakharov V.V., Yakhno N.N. Primary progressive aphasia syndrome. Neurological journal №5; 2014; 22-28. |
[11] | Yakhno N.N., Zakharov V.V., Lokshina A.B., Koberskaya N.N., Mkhitaryan E.A. Dementia. Guide for doctors. M.: MEDpress-inform ; 2010. |
[12] | Yakhno N.N., Shtulman D.R. Diseases of the nervous system; Manual for doctors; Moscow "Medicine" 2003, pp. 193-203. |
[13] | Chare L., Hodges JR, Leyton CE, et al. New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications // J Neurol Neurosurg Psychiatry. - 2014. -Vol. 85. - P. 866-871. |
[14] | Coleman LW, Digre KB, Stephenson GM, Townsend JJ Autopsy-proven, sporadic pick disease with onset at age 25 years. Arch. Neurol. 2002; 59 (5): 856-59. |
[15] | Ferrari R, Hernandez DG, Nalls MA, Rohrer JD., et al., Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014 Jul; 13(7): 686-699. |
[16] | Geerlings MI, Sigurdsson S, Eiriksdottir G, et.al., Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia. Neurology. 2015 Sep 15; 85(11): 976-983. |
[17] | Gorno-Tempini ML, Dronkers NF, Rankin KP et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann. Neurology. 2004; 55: 335-46. |
[18] | Gorno-Tempini ML, Hillis AE, Weintraub S. et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76: 1006-14. |
[19] | Ismail H. Zwain, Samuel S. C. Yen, Dehydroepiandrosterone: Biosynthesis and Metabolism in the Brain, Endocrinology, Volume 140, Issue 2, 1 February 1999, Pages 880–887. |
[20] | Joels, M., Pu, Z., Wiegert, O., Oitzl, M. S., & Krugers, H. J. (2006). Learning under Stress: How Does It Work? Trends in Cognitive Sciences, 10, 152-158. |
[21] | K almijn S., Launer LJ, Stolk RP, de Jong FH, Pols HA, Hofman A., Breteler MM, Lamberts SW A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. // J Clin Endocrinol Metab. 1998 Oct; 83(10): 3487-3492. |
[22] | Kimonides VG, Spillantini MG, Sofroniew MV et al. // Neuroscience. - 1999. - Vol.89, No. 2. - P. 429-436. |
[23] | Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behavior and cognition. Nat Rev Neurosci. 2009; 10(6): 434-445. |
[24] | Lupien, S. J. et al. Hippocampal volume is as variable in young as in older adults: implications for the notion of hippocampal atrophy in humans. Neuroimage 34, 479–485 (2007). |
[25] | Majewska MD. Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. // Ann NY Acad Sci. - 1995 Dec 29;774:111-120. |
[26] | McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007 Jul; 87(3): 873-904. |
[27] | Mesulam MM Slowly progressive aphasia without generalized dementia. Ann. Neurol. 1982; 11: 592-8. |
[28] | Mesulam MM, Wieneke C., Rogalski E. Quantitative template for subtyping primary progressive aphasia. Arch. Neurol. 2009; 66: 1545-51. |
[29] | Mesulam M.M., Wieneke C., Thompson C. et al. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain. 2012; 135: 1537-53. |
[30] | Neary D., Snowden JS, Gustafson L. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-54. |
[31] | Ouanes S, Castelao E, von Gunten A, Vidal PM, Preisig M, Popp J. Personality, Cortisol, and Cognition in Non-demented Elderly Subjects: Results from a Population-Based Study. Front Aging Neurosci. 2017 Mar 14; 9: 63. |
[32] | Ouanes, S., & Popp, J. (2019). High cortisol and the risk of dementia and Alzheimer's disease: A review of the literature. Frontiers in Aging Neuroscience, 11, Article 43. |
[33] | Pressman PS, Miller BL. Diagnosis and management of behavioral variant frontotemporal dementia. Biological Psychiatry. 2014 Apr; 75(7): 574-581. |
[34] | Rothman SM, Mattson MP. Adverse stress, hippocampal networks, and Alzheimer's disease. Neuromolecular Med. 2010 Mar; 12(1): 56-70. |
[35] | Wolkowitz OM, Burke H, Epel ES, Reus VI. Glucocorticoids. Mood, memory, and mechanisms. Ann NY Acad Sci. 2009 Oct; 1179: 19 -40. |